Molson Coors Beverage Company is expanding its U.S. non-alc portfolio through a new strategic partnership with Fevertree Drinks plc, one of the world leading suppliers of premium carbonated drinks and mixers.

Starting February 1, 2025, Molson Coors will assume exclusive commercialisation rights to Fever-Tree’s award-winning lineup of tonics, ginger beers, cocktail mixers and more in the U.S. and will be responsible for co-manufactured production, marketing, sales and distribution of the brand in the U.S. The move is a significant step forward in Molson Coors’ strategic ambition to build a total-beverage portfolio for a wide range of consumer preferences across traditional alcohol occasions and non-alc occasions alike.

“Our strategic partnership with Fever-Tree in the U.S. is a meaningful step in Molson Coors’ journey to becoming a total-beverage company with a winning portfolio of drinks for a wide variety of consumer occasions. We’ve made progress here, and today we are building on that progress in a significant way with Fever-Tree as the latest and largest non-alc brand to join our portfolio,” Molson Coors Chief Executive Officer Gavin Hattersley said. “The U.S. is our biggest global market by revenue, and the same is true for Fever-Tree, so we believe this partnership provides ample opportunity for our teams to build on the strong success Fever-Tree has achieved to date. Our customers have been asking for a brand just like Fever-Tree from us, and by leveraging the scale, strong relationships and expertise of our team at Molson Coors, I’m confident in the road ahead for Fever-Tree as part of Molson Coors’ growing set of non-alc offerings in the U.S.”

Established in the UK in 2004, Fever-Tree has become a proven leader in a high-growth, above premium space. Drinks International voted it the ‘Number One Top Selling Mixer’ and ‘Number One Top Trending Mixer’ for 11 years running, while the New York International Spirits Competition voted it ‘Mixer Brand of the Year’ for four years running. In the U.S., Fever-Tree’s largest global market by revenue, the brand has consistently built on its first-mover advantage, and in doing so has become the #1 tonic and ginger beer brands nationwide, per Nielsen [since 2007].

Molson Coors plans to build on the position Fever-Tree has already established in the U.S. by leveraging its core strengths, commercial scale and supply chain expertise to expand distribution, grow brand awareness, and create a solid runway for long-term growth in the U.S. market.

Underpinning the partnership and reflecting Molson Coors’ long-term focus on – and belief in – the opportunity, the company has agreed to acquire an 8.5% stake in Fevertree Drinks plc, resulting in Molson Coors becoming Fever-Tree’s second largest shareholder.

The partnership with Fever-Tree builds on Molson Coors’ strong recent momentum in the advancement of its Beyond Beer and premiumization strategy. The company took a majority stake in ZOA Energy in November 2024 and has since expanded distribution into new accounts and channels. Additionally, Molson Coors is preparing to bring Naked Life, Australia’s #1 non-alc RTD cocktail, to the U.S. this spring.

Molson Coors and Fever-Tree’s strategic partnership is subject to customary closing conditions.